SURTECO GROUP SE/ DE0005176903 /
2024-05-29 9:45:16 AM | Chg. +0.10 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
16.85EUR | +0.60% | 198 Turnover: 3,336.30 |
-Bid Size: - | -Ask Size: - | 258.95 mill.EUR | 5.99% | 5.42 |
GlobeNewswire
10:05 PM
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
GlobeNewswire
10:05 PM
Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
10:05 PM
iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference
GlobeNewswire
10:05 PM
Consolidated Water Announces Settlement of Dispute with Mexico Regarding Playas de Rosarito, Baja Ca...
GlobeNewswire
10:05 PM
OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference
GlobeNewswire
10:05 PM
HashiCorp and AWS sign strategic collaboration agreement to expand joint product and go-to-market in...
GlobeNewswire
10:05 PM
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment o...
GlobeNewswire
10:05 PM
Sportsman’s Warehouse Holdings, Inc. Announces First Quarter 2024 Financial Results
GlobeNewswire
10:05 PM
Ultragenyx to Participate at Goldman Sachs 45th Annual Global Healthcare Conference
Newsfile Corp
10:02 PM
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cambium Networks Corporation Investors to Secure Counsel...
GlobeNewswire
10:01 PM
Ascendis Pharma to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
10:01 PM
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
10:01 PM
Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
10:00 PM
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)